At 4 weeks , the mean percentage of time in the therapeutic range was 45.2 % in the genotype-guided group and 45.4 % in the clinically guided group ( adjusted mean difference , [ genotype-guided group minus clinically guided group ] , -0.2 ; 95 % confidence interval , -3.4 to 3.1 ; P = 0.91 ) .